Setting the Stage for AI in the Pharma Cold Chain
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
Adverse event (AE) case intake in Life Sciences is crying out for disruption by AI. And now, at last, Generative AI and Large Language Models…
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced…
The breakneck pace of digital transformation spurred by COVID-19 continued to reshape the life sciences landscape in 2023. Rather than a single watershed moment, this…
At the heart of Genomics England, we nurture a vision: a world where everyone benefits from genomic healthcare. This aspiration is expressed in supporting the…
The last decade has brought about many developments to genomics, stem cell research, cancer therapies and immunotherapy – to name just a few areas. Hand…
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…